-
Something wrong with this record ?
Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
N. Kudlova, JB. De Sanctis, M. Hajduch
Language English Country Switzerland
Document type Journal Article, Review
Grant support
LM2018133
Ministry of School, Education, Youth and Sports of the Czech Republic
CZ.02.1.01/0.0/0.0/16_019/0000868
Ministry of School, Education, Youth and Sports of the Czech Republic
TE02000058
Technological agency of the Czech Republic
IGA_LF_2021_036
Palacky University in Olomouc
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
35456986
DOI
10.3390/ijms23084168
Knihovny.cz E-resources
- MeSH
- Biomarkers MeSH
- Cell Cycle Checkpoints MeSH
- DNA Damage MeSH
- Cellular Senescence * genetics MeSH
- Aging * genetics MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Cellular senescence is defined as irreversible cell cycle arrest caused by various processes that render viable cells non-functional, hampering normal tissue homeostasis. It has many endogenous and exogenous inducers, and is closely connected with age, age-related pathologies, DNA damage, degenerative disorders, tumor suppression and activation, wound healing, and tissue repair. However, the literature is replete with contradictory findings concerning its triggering mechanisms, specific biomarkers, and detection protocols. This may be partly due to the wide range of cellular and in vivo animal or human models of accelerated aging that have been used to study senescence and test senolytic drugs. This review summarizes recent findings concerning senescence, presents some widely used cellular and animal senescence models, and briefly describes the best-known senolytic agents.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018822
- 003
- CZ-PrNML
- 005
- 20220804135123.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms23084168 $2 doi
- 035 __
- $a (PubMed)35456986
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kudlova, Natalie $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77147 Olomouc, Czech Republic $1 https://orcid.org/0000000285109878
- 245 10
- $a Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs / $c N. Kudlova, JB. De Sanctis, M. Hajduch
- 520 9_
- $a Cellular senescence is defined as irreversible cell cycle arrest caused by various processes that render viable cells non-functional, hampering normal tissue homeostasis. It has many endogenous and exogenous inducers, and is closely connected with age, age-related pathologies, DNA damage, degenerative disorders, tumor suppression and activation, wound healing, and tissue repair. However, the literature is replete with contradictory findings concerning its triggering mechanisms, specific biomarkers, and detection protocols. This may be partly due to the wide range of cellular and in vivo animal or human models of accelerated aging that have been used to study senescence and test senolytic drugs. This review summarizes recent findings concerning senescence, presents some widely used cellular and animal senescence models, and briefly describes the best-known senolytic agents.
- 650 12
- $a stárnutí $x genetika $7 D000375
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a kontrolní body buněčného cyklu $7 D059447
- 650 12
- $a stárnutí buněk $x genetika $7 D016922
- 650 _2
- $a poškození DNA $7 D004249
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a De Sanctis, Juan Bautista $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77147 Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine Czech Advanced Technologies and Research Institute, Palacky University, 77147 Olomouc, Czech Republic
- 700 1_
- $a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77147 Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine Czech Advanced Technologies and Research Institute, Palacky University, 77147 Olomouc, Czech Republic $1 https://orcid.org/000000024834908X $7 xx0050218
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 8 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35456986 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135117 $b ABA008
- 999 __
- $a ok $b bmc $g 1822427 $s 1170065
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 23 $c 8 $e 20220410 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a LM2018133 $p Ministry of School, Education, Youth and Sports of the Czech Republic
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000868 $p Ministry of School, Education, Youth and Sports of the Czech Republic
- GRA __
- $a TE02000058 $p Technological agency of the Czech Republic
- GRA __
- $a IGA_LF_2021_036 $p Palacky University in Olomouc
- LZP __
- $a Pubmed-20220720